CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia... Show more
Coca-Cola Europacific Partners is the world's largest independent bottler of Coca-Cola by revenue. The company buys concentrate from The Coca-Cola Company, then manufactures, distributes, and sells beverages across 31 countries in Europe and the Asia-Pacific region, serving nearly 600 million consumers and more than 4 million retail and hospitality customers.
Its portfolio spans sparkling soft drinks, water, juice, and energy drinks, including Coca-Cola, Coke Zero, and Monster, the latter under a partnership with Monster Beverage (MNST). CCEP is listed on Nasdaq, Euronext Amsterdam, the London Stock Exchange, and Spanish exchanges, and is a constituent of both the Nasdaq 100 and FTSE 100 indices. Investors follow the stock for its scale, defensive consumer demand, pricing power, and consistent capital returns through dividends and buybacks.
Over the last 30 days, CCEP rose roughly 11.3%, from a closing price of about $101.71 on September 30 to $113.22 on October 30. The move was driven by a sharp mid-October rally following the company's third-quarter trading update, which carried the shares above $114 intraday and near their 52-week high.
The trailing quarter tells a more volatile story. The stock began the period near $109 in late July, weakened through August and September to a low around $99 in mid-September, then rebounded strongly to finish October above $113. On a net basis, the stock gained about 4% to 5% over the trailing three months, but the round trip reflects meaningful intra-period swings rather than a steady climb.
The primary catalyst was the company's third-quarter update in mid-October, which showed volume and revenue growth led by strong performances in Europe and Asia-Pacific. Management highlighted Monster and Coke Zero as key growth drivers and reaffirmed full-year guidance, easing earlier concerns about a cautious European consumer.
Supportive signals from the brand owner also helped. In late October, The Coca-Cola Company topped earnings forecasts and raised its full-year outlook again, providing a favorable read on global beverage demand ahead of CCEP's own reporting.
Analyst activity reinforced the move. Barclays maintained a Buy rating with a $112 price target, Wells Fargo reaffirmed Buy with a $115 target, and Goldman Sachs also reiterated a Buy. UBS held a Neutral rating with a $107 target, while Bernstein kept a Hold, reflecting a range of views on valuation after a strong run.
The company's €1 billion share buyback program, announced in February 2026, continued through October, with regular repurchases across U.S. and London venues. Additionally, Invesco disclosed an increased major shareholding of roughly 5.3% of voting rights, a signal of sustained institutional interest.
The broader quarterly trend reflects a defensive consumer-staples business navigating mixed sentiment. Early in the quarter, shares pulled back as investors weighed European affordability pressures, rising input costs, and a valuation premium after a strong first half. The company's half-year results, for the six months ended July 3, 2026, showed revenue of €10.72 billion, up 4.4% on a comparable basis and 6.1% currency-neutral, with diluted earnings per share rising 9.2% — a resilient result that nonetheless drew a cautious market reaction on the outlook.
The mid-September low near $99 marked the trough of that reassessment. The recovery in October was driven by the Q3 update, reaffirmed guidance, favorable weather and improving European carbonated-drink consumption trends, and continued execution of the buyback. The combination of solid fundamentals and returning investor confidence lifted the stock back toward its 52-week high.
Tickeron's Trending AI Robots page showcases a curated selection of algorithmic trading bots. While Tickeron offers hundreds of AI-driven bots that trade thousands of tickers across various markets, only the top-performing and most relevant bots appear in this featured section. Each bot operates with its own strategy, timeframe, and performance metrics, ranging from short-term swing trades to longer-horizon approaches. The page is designed to help traders quickly identify strategies that are currently generating notable results. Readers interested in automated, data-driven trading signals can explore the section to see which bots are trending now.
Looking ahead, investors will focus on the company's next trading statement and any updates to full-year guidance. Volume trends across Europe and Asia-Pacific, pricing, and the performance of zero-sugar and energy drink lines will be closely watched, as will the impact of input costs such as sugar, packaging, and energy.
Macroeconomic factors remain important, including European consumer spending, currency swings, and evolving regulations on sugar and packaging. Progress on the €1 billion buyback and any changes to analyst price targets could also influence sentiment. These factors are forward-looking observations, not financial advice or predictions of future performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for CCEP crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on CCEP as a result. In 62 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CCEP just turned positive on September 29, 2026. Looking at past instances where CCEP's MACD turned positive, the stock continued to rise in 23 of 47 cases over the following month. The odds of a continued upward trend are 49%.
CCEP moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in 190 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Aroon Indicator entered an Uptrend today. In 162 of 282 cases where CCEP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The 10-day RSI Indicator for CCEP moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 8 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 22%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 32 of 71 cases where CCEP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.
CCEP broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.145) is normal, around the industry mean (-4.128). P/E Ratio (26.032) is within average values for comparable stocks, (25.797). Projected Growth (PEG Ratio) (2.715) is also within normal values, averaging (3.732). Dividend Yield (0.033) settles around the average of (0.039) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (2.785).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a bottling company with interests in marketing, production and distribution of Coca-Cola products
Industry BeveragesNonAlcoholic